Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial.

Blood
Michel DuvalNoël Philippe

Abstract

Asparaginase is an enzyme used in the treatment of acute lymphoblastic leukemia and lymphoblastic lymphoma in children. It has minimal bone marrow toxicity. Its major side effects are anaphylaxis, pancreatitis, diabetes, coagulation abnormalities, and thrombosis, especially intracranial. It is derived from 2 different sources: Escherichia coli and Erwinia chrysanthemi. Nonrandomized clinical studies have suggested a similar efficacy of these 2 types of asparaginases and a lower toxicity for Erwinia-asparaginase. The European Organisation for Research and Treatment of Cancer-Children's Leukemia Group (EORTC-CLG) 58881 trial randomized 700 children with acute lymphoblastic leukemia or lymphoblastic lymphoma to either E coli- or Erwinia-asparaginase at the same dosage of 10 000 IU/m(2) twice weekly to compare toxicity and efficacy. Coagulation abnormalities were more frequent in the E coli-asparaginase than in the Erwinia-asparaginase arm of the study (30.2% versus 11.9%, P <.0001). The incidence of other toxicity was not significantly different. In the Erwinia-asparaginase arm, more patients failed to achieve complete remission (4.9% versus 2.0%; P =.038) and the relapse rate was higher, leading to shorter event-free survival (ha...Continue Reading

Citations

Oct 4, 2002·Hematological Oncology
Oct 15, 2013·Cancer Chemotherapy and Pharmacology·Tomoko YokosukaShumpei Yokota
Feb 3, 2009·Clinical and Experimental Medicine·Beata Zalewska-SzewczykWojciech Młynarski
Jul 1, 2007·Current Hematologic Malignancy Reports·Paul S Gaynon
Jul 1, 2008·Current Hematologic Malignancy Reports·Daniel J DeAngelo, Richard M Stone
Feb 28, 2007·Current Neurology and Neuroscience Reports·Jessica Carpenter, Tammy Tsuchida
Sep 1, 2006·Current Treatment Options in Neurology·Janet L Franklin, Jonathan Finlay
Jun 23, 2009·Applied Biochemistry and Biotechnology·R S PrakashamP N Sarma
Jan 13, 2004·Biochemical and Biophysical Research Communications·Yoichi MizukamiKoichiro Takeshige
Jun 26, 2009·The New England Journal of Medicine·Ching-Hon PuiMary V Relling
Apr 13, 2012·The New England Journal of Medicine·Martin SchrappeMartin Zimmermann
Jan 13, 2006·The New England Journal of Medicine·Ching-Hon Pui, William E Evans
Jan 7, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jason R CantorGeorge Georgiou
Feb 13, 2013·Current Opinion in Oncology·Carmelo RizzariMartin Schrappe
Sep 23, 2009·Journal of Pediatric Hematology/oncology·Judith Flores-CalderónAlfonso Yamamoto-Nagano
Aug 21, 2010·Journal of Pediatric Hematology/oncology·Elizabeth A Raetz, Wanda L Salzer
Mar 3, 2006·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Linnea E K WikmanAnastassios C Papageorgiou
Aug 6, 2008·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Prathusha DhavalaAnastassios C Papageorgiou
Mar 24, 2007·The Journal of Clinical Investigation·Shotaro IwamotoDario Campana
Dec 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ching-Hon PuiMary V Relling
Jul 12, 2005·Biological Chemistry·Anne WernerHans-Joachim Müller
Feb 16, 2013·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Chasity M SheltonMichael L Christensen
Feb 12, 2014·Cancer Chemotherapy and Pharmacology·Ashkan EmadiEdward A Sausville
Dec 18, 2013·Therapeutic Drug Monitoring·Claudia Lanvers-KaminskyJoachim Boos
May 8, 2013·Journal of Bioscience and Bioengineering·Shahid Mahmood Chohan, Naeem Rashid
Aug 27, 2009·Biologics : Targets & Therapy·Riccardo Masetti, Andrea Pession
Oct 26, 2010·Haematologica·Mathilde Hunault-BergerUNKNOWN Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL)
Jan 15, 2005·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Stefano MazzoleniModesto Carli
Feb 16, 2006·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Inge M AppelRob Pieters
Sep 24, 2013·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Susanna RantaAnne M-T Mäkipernaa
Apr 14, 2015·Critical Reviews in Microbiology·Prajna Rao KrishnapuraSandeep Subramanya
Jan 15, 2015·Leukemia & Lymphoma·Barbara Asselin, Carmelo Rizzari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.